The price-to-earnings ratio for Encompass Health Corp (NYSE: EHC) is above average at 23.28x. The 36-month beta value for EHC is also noteworthy at 0.92. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for EHC is 99.13M, and at present, short sellers hold a 1.78% of that float. The average trading volume of EHC on May 10, 2024 was 688.88K shares.
EHC) stock’s latest price update
Encompass Health Corp (NYSE: EHC)’s stock price has plunge by -0.03relation to previous closing price of 86.37. Nevertheless, the company has seen a 3.76% surge in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-05-08 that Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical – Outpatient and Home Healthcare industry. DVA, EHC, OPCH and PNTG are well-poised to gain.
EHC’s Market Performance
EHC’s stock has risen by 3.76% in the past week, with a monthly rise of 5.73% and a quarterly rise of 18.39%. The volatility ratio for the week is 1.64% while the volatility levels for the last 30 days are 1.88% for Encompass Health Corp The simple moving average for the last 20 days is 4.78% for EHC stock, with a simple moving average of 21.64% for the last 200 days.
Analysts’ Opinion of EHC
Many brokerage firms have already submitted their reports for EHC stocks, with Barclays repeating the rating for EHC by listing it as a “Overweight.” The predicted price for EHC in the upcoming period, according to Barclays is $95 based on the research report published on March 06, 2024 of the current year 2024.
Barclays, on the other hand, stated in their research note that they expect to see EHC reach a price target of $57. The rating they have provided for EHC stocks is “Equal Weight” according to the report published on March 14th, 2023.
UBS gave a rating of “Buy” to EHC, setting the target price at $98 in the report published on September 24th of the previous year.
EHC Trading at 8.15% from the 50-Day Moving Average
After a stumble in the market that brought EHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.30% of loss for the given period.
Volatility was left at 1.88%, however, over the last 30 days, the volatility rate increased by 1.64%, as shares surge +7.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +15.82% upper at present.
During the last 5 trading sessions, EHC rose by +3.56%, which changed the moving average for the period of 200-days by +30.44% in comparison to the 20-day moving average, which settled at $82.69. In addition, Encompass Health Corp saw 29.41% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EHC starting from Darby John Patrick, who sale 14,543 shares at the price of $83.94 back on May 06 ’24. After this action, Darby John Patrick now owns 84,773 shares of Encompass Health Corp, valued at $1,220,739 using the latest closing price.
CARMICHAEL GREG D, the Director of Encompass Health Corp, purchase 2,000 shares at $83.73 during a trade that took place back on May 03 ’24, which means that CARMICHAEL GREG D is holding 17,050 shares at $167,460 based on the most recent closing price.
Stock Fundamentals for EHC
Current profitability levels for the company are sitting at:
- 0.13 for the present operating margin
- 0.56 for the gross margin
The net margin for Encompass Health Corp stands at 0.08. The total capital return value is set at 0.11. Equity return is now at value 24.81, with 6.47 for asset returns.
Based on Encompass Health Corp (EHC), the company’s capital structure generated 0.58 points at debt to capital in total, while cash flow to debt ratio is standing at 0.36. The debt to equity ratio resting at 1.39. The interest coverage ratio of the stock is 4.43.
Currently, EBITDA for the company is 1.01 billion with net debt to EBITDA at 2.63. When we switch over and look at the enterprise to sales, we see a ratio of 2.31. The receivables turnover for the company is 8.0for trailing twelve months and the total asset turnover is 0.8. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.37.
Conclusion
In summary, Encompass Health Corp (EHC) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
